国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
GEMCITABINE HYDROCHLORIDE;;GEMCITABINE HYDROCHLORIDE;;GEMCITABINE HYDROCHLORIDE
香港商艾維斯有限公司台灣分公司 台北市中正區忠孝東路二段116號10樓 (70762585)
L01BC05
凍晶注射劑
GEMCITABINE HYDROCHLORIDE (1010000610) (eq. to Gemcitabine 200mg)MG; GEMCITABINE HYDROCHLORIDE (1010000610) (eq. to Gemcitabine 1000mg)MG; GEMCITABINE HYDROCHLORIDE (1010000610) eq. to Gemcitabine 2000mg)MG
小瓶;;盒裝
製 劑
限由醫師使用
PHARMACHEMIE B.V. SWENSWEG 5,2031 GA HAARLEM,THE NETHERLANDS NL
gemcitabine
非小細胞肺癌、胰臟癌、膀胱癌。Gemcitabine與paclitaxel併用,可使用於曾經使用過Anthracycline之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(Platinum-Based)治療後復發且間隔至少6個月之卵巢癌,作為第二線治療。
註銷日期: 2019/04/15; 註銷理由: 自請註銷; 有效日期: 2023/06/07; 英文品名: Gemcitabine Teva Powder for Solution for Infusion
已註銷
2013-06-07
Gemcitabine HCl Gemcitabine HCl 2 -deoxy- 2 , 2 -difluorocytidine monohydrochloride( ) Gemcitabine HCl C 9 H 11 F 2 N 3 O 4 HC l 299 . 66 Gemcitabine HCl 200 1 2 Gemcitabine HCl( ) ( 200 1 2 ) ( ) ( 20 . 7 103 . 7 207 . 3 ) / Gemcitabine DNA (S- ) G 1 /S Gemcitabine nucleoside kinases diphosphate(dFdCDP) triphosphate(dFdCTP) nucleosides Gemcitabin DNA gemcitabine diphosphate ribonucleotide DNA deoxynucleoside triphosphates deoxynucleotides dCTP Gemcitabine triphosphate dCTP DNA dCTP ( dip hosphate ) Gemcitabine triphosphate DNA ( ) Gemcitabine nucleotide DNA nucleotide DNA DNA DNA polymerase epsilon Gemcitabine nucleotide DNA (masked chain termination) CEM T Gemcitabine internucleosomal DNA Gemcitabine cisplatin Cisplatin Gemcitabine triphosphate DNA Gemcitabine cisplatin LX- 1 CALU- 6 NCI-H 460 NCI-H 520 Gemcitabine Lewis cisplatin cisplatin 4 Gemcitabine 5 1000 / / 30 Gemcitabine 92 - 98 % Gemcitabine(< 10 %) uracil 2 -deoxy- 2 , 2 -difluorouridine(dFdU) 99 % dFdU Gemcitabine Gemcitabine 353 (< 70 ) ( 70 - 285 ) Gemcitabine 500 - 3600 / Gemcitabine 2 -compartment Gemcitabine Gemcitabine 32 - 94 245 - 638 70 50 / Gemcitabine 370 / Gemcitabine 30 dFdU( ) Gemcitabine Gemcitabine triphosphate 1 . 7 - 19 . 4 Gemcitabine ( 1 8 1250 mg/m 2 ) cisplatin ( 1 75 mg/m 2 ) Gemcitabine 1 128 L/hr/m 2 8 107 L/hr/m 2 Cisplatin 3 . 94 mL/min/m 2 134 ( - ) Gemcitabine paclitaxel ( ) paclitaxel Gemcitabine Gemcitabine carboplatin Gemcitabine carboplatin - Gemcitabine 356 (advanced) (platinum-based) 6 : 21 1 8 Gemcitabine 1000 mg/m 2 1 Gemcitabine carboplatin AUC 4 21 1 carboplatin AUC 5 (progression free survival, PFS) Gemcitabine Carboplatin (PFS) 75 % Carboplatin 120 13 Gemcitabine Gemcitabine/Carboplatin ( 178 ) Carboplatin ( 178 ) ( 95 % ), ( 95 % ) 8 . 3 ( 8 . 0 , 9 . 7 ) 5 . 8 ( 5 . 2 , 7 . 1 ) p= 0 . 0038 d 0 . 72 ( 0 . 57 , 0 . 90 ) ( 95 % ), ( 95 % ) a ( 95 % ) 18 . 0 ( 16 . 2 , 20 . 3 ) 17 . 3 ( 15 . 2 , 19 . 3 ) P= 0 . 8977 d 0 . 98 ( 0 . 78 , 1 . 24 ) 0 . 86 ( 0 . 67 , 1 . 10 ) CR PR+PRNM b 42 . 2 % 14 . 6 % 32 . 6 阅读完整的文件